BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LISCure Biosciences announces research collaboration with Mayo Clinic for rare liver diseases

LISCure has been conducting joint research with Mayo Clinic for NASH drugs since 2021, and this new collaboration is an agreement signed under the leadersh...

January 07, 2022 | News

GC Cell seeks to expand global availability of Immuncell-LC® for liver cancer

Rivaara Immune to lead development and commercialization in India GC Cell (KOSDAQ:144510) and Rivaara Immune Private Limited today announced that they hav...

January 05, 2022 | News

Celltrion plans to provide dual treatment options for COVID-19 in South Korea

CT-P63 demonstrated a well- established safety profile in the global Phase I trial CT-P63 maintained strong neutralising ability against the Omicron var...

January 04, 2022 | News

WuXi Biologics, ImmuneOncia Sign MOU for Development and Manufacturing of Anti-PD-L1/CD47 Bispecific Antibody

Within the partnership, ImmuneOncia will have access to WuXi Biologics' integrated services in cell line development, cell culture development, biologics m...

December 28, 2021 | News

Curocell, Breaks Ground on 'CAR-T Manufacturing GMP Facility'

The GMP Facility for commercial manufacturing CAR-T Cell therapy and R&D Center for further pipeline development are constituting the 17,325 square-met...

December 24, 2021 | News

Novavax and SK bioscience Expand Manufacturing Agreement

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...

December 24, 2021 | News

Scientists from A*STAR GIS awarded CZI Ancestry Network Grant to investigate immune diversity in Singapore and Asia

A team of researchers, led by the Agency for Science, Technology and Research’s (A*STAR) Genome Institute of Singapore (GIS), was awarded the p...

December 20, 2021 | News

Everest Medicines to treat Triple-Negative Breast Cancer in South Korea

Everest Medicines Limited (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing tran...

December 15, 2021 | News

Samsung Biologics , AstraZeneca expand strategic manufacturing partnership to include COVID-19 and cancer therapy

The partnership is based on an expanded deal this year in May 2021 which followed the signing of a long-term strategic agreement made in Sep...

December 14, 2021 | News

Seegene Rapidly Introduces New PCR Test that Identifies the Omicron Variant

South Korea’s leading molecular diagnostics company, today unveiled another series of diagnostic test that detects the ever-changing COVID-19 variant...

December 13, 2021 | News

Samsung Biologics adds to global ISO certifications with Quality Management System

Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization, held an award ceremony with the British Standa...

December 08, 2021 | News

Seegene's PCR test combining numerous technologies to detect the new Omicron variant

Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, confirmed today that its Allplex™ SARS-CoV-2 Master test ...

December 06, 2021 | News

Prestige BioPharma Announces Grand Opening of Global-Scale Vaccine Center in South Korea

The opening ceremony was held on December 01, 2021 at the Vaccine Center in Osong Campus. The ceremony was attended by many distinguished guests including ...

December 02, 2021 | News

Seegene's High Multiplex PCR Assay Capable of Detecting New Omicron Variant

Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, today confirmed that its Allplex™ SARS-CoV-2 Master Assay i...

December 01, 2021 | News

Stay Connected